A citation-based method for searching scientific literature

Alex Mas Monteys, Shauna A Ebanks, Megan S Keiser, Beverly L Davidson. Mol Ther 2017
Times Cited: 140



F Ann Ran, Le Cong, Winston X Yan, David A Scott, Jonathan S Gootenberg, Andrea J Kriz, Bernd Zetsche, Ophir Shalem, Xuebing Wu, Kira S Makarova, Eugene V Koonin, Phillip A Sharp, Feng Zhang. Nature 2015
Times Cited: 1366




List of shared articles



Times cited

Revisiting gene delivery to the brain: silencing and editing.
João Conniot, Sepehr Talebian, Susana Simões, Lino Ferreira, João Conde. Biomater Sci 2021
4

Approach for in vivo delivery of CRISPR/Cas system: a recent update and future prospect.
Yu-Fan Chuang, Andrew J Phipps, Fan-Li Lin, Valerie Hecht, Alex W Hewitt, Peng-Yuan Wang, Guei-Sheung Liu. Cell Mol Life Sci 2021
6

CRISPR/Cas-Dependent and Nuclease-Free In Vivo Therapeutic Gene Editing.
Ishani Dasgupta, Terence R Flotte, Allison M Keeler. Hum Gene Ther 2021
6

Chromatin Alterations in Neurological Disorders and Strategies of (Epi)Genome Rescue.
Marcin Janowski, Małgorzata Milewska, Peyman Zare, Aleksandra Pękowska. Pharmaceuticals (Basel) 2021
0

Haplotyping by CRISPR-mediated DNA circularization (CRISPR-hapC) broadens allele-specific gene editing.
Jiaying Yu, Xi Xiang, Jinrong Huang, Xue Liang, Xiaoguang Pan, Zhanying Dong, Trine Skov Petersen, Kunli Qu, Ling Yang, Xiaoying Zhao,[...]. Nucleic Acids Res 2020
2

Genome editing methods in animal models.
Hyunji Lee, Da Eun Yoon, Kyoungmi Kim. Anim Cells Syst (Seoul) 2020
12

Allele-specific genome targeting in the development of precision medicine.
Junjiao Wu, Beisha Tang, Yu Tang. Theranostics 2020
8

Genome and base editing for genetic hearing loss.
Philipp Niggemann, Bence György, Zheng-Yi Chen. Hear Res 2020
6

The delivery challenge: fulfilling the promise of therapeutic genome editing.
Joost van Haasteren, Jie Li, Olivia J Scheideler, Niren Murthy, David V Schaffer. Nat Biotechnol 2020
41

CRISPR/Cas: a potential gene-editing tool in the nervous system.
Yanxia Gao, Kexin Gao, Hui Yang. Cell Regen 2020
2

Delivery Approaches for Therapeutic Genome Editing and Challenges.
Ilayda Ates, Tanner Rathbone, Callie Stuart, P Hudson Bridges, Renee N Cottle. Genes (Basel) 2020
13

Delivery of CRISPR/Cas9 by Novel Strategies for Gene Therapy.
Le Wang, Wenfu Zheng, Shaoqin Liu, Bing Li, Xingyu Jiang. Chembiochem 2019
21

Basic and Clinical Application of Adeno-Associated Virus-Mediated Genome Editing.
Xiubin He, Haihua Xie, Xiexie Liu, Feng Gu. Hum Gene Ther 2019
3

CRISPR to the Rescue: Advances in Gene Editing for the FMR1 Gene.
Carolyn M Yrigollen, Beverly L Davidson. Brain Sci 2019
8

Next Generation Precision Medicine: CRISPR-mediated Genome Editing for the Treatment of Neurodegenerative Disorders.
Sudhanshu P Raikwar, Nidhi S Kikkeri, Ragha Sakuru, Daniyal Saeed, Haris Zahoor, Keerthivaas Premkumar, Shireen Mentor, Ramasamy Thangavel, Iuliia Dubova, Mohammad Ejaz Ahmed,[...]. J Neuroimmune Pharmacol 2019
9

CRISPR/Cas: An intriguing genomic editing tool with prospects in treating neurodegenerative diseases.
Safikur Rahman, Manali Datta, Jihoe Kim, Arif Tasleem Jan. Semin Cell Dev Biol 2019
6

CRISPR-Cas9-Mediated Genome Editing Increases Lifespan and Improves Motor Deficits in a Huntington's Disease Mouse Model.
Freja K Ekman, David S Ojala, Maroof M Adil, Paola A Lopez, David V Schaffer, Thomas Gaj. Mol Ther Nucleic Acids 2019
29

CRISPR-engineered genome editing for the next generation neurological disease modeling.
Weijun Feng, Hai-Kun Liu, Daisuke Kawauchi. Prog Neuropsychopharmacol Biol Psychiatry 2018
6